Company / Cash per Share
LivaNova Cash per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$11.69
FY2025
5-year range
$4.02 / $11.69
FY2021-FY2025
Trend
+47.0%
vs FY2024
Sector context
#21 of 146
Health Care
What the data says
LivaNova's cash per share of $11.69 is higher than 86% of companies in the Health Care sector (FY2025). Cash per Share has increased for 3 consecutive years, from $4.02 in FY2022 to $11.69 in FY2025.
Based on SEC 10-K filings.
11.69 in FY2025 with a 5-year CAGR of +17.5%. Top quartile in the Health Care sector.
Improved from $4.98 to $11.69 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +42.7%
- 5-Year CAGR
- +17.5%
- 10-Year CAGR
- -
Sector benchmark
Top 14% in Health CareTop 14% of 146This company $11.69 Sector average $27.70
▼
-57.8% below sector average
Key checks
Key Insights
- LivaNova's cash per share has grown for 3 consecutive years.
- In FY2025, cash per share increased 47.0% year-over-year.
- Ranks #21 out of 146 companies in the Health Care sector.
- Lowest cash per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 0.84 (distress zone, below 1.8 threshold)
- Negative profit margin: -16.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $11.69 | +47.0% |
| FY2024 | $7.95 | +59.9% |
| FY2023 | $4.98 | +23.7% |
| FY2022 | $4.02 | -5.9% |
| FY2021 | $4.27 | -18.1% |
| FY2020 | $5.22 | +311.5% |
| FY2019 | $1.27 | +29.7% |
| FY2018 | $0.98 | +50053.2% |
| FY2017 | $0.00 | -99.9% |
| FY2016 | $1.53 | -55.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026